#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4703498	B	Inhibition of recombinant BMX (unknown origin) at 10 uM using fluorescence-labeled peptide as substrate incubated for 15 mins followed by substrate addition and measured after 90 mins by electrophoretic mobility assay relative to control	Homo sapiens	1	ALA4699558	single protein format	Scientific Literature
2.	ALA4703499	F	Antibacterial activity against Methicillin-resistant Staphylococcus aureus by CLSI method	Staphylococcus aureus	7	ALA4699558	organism-based format	Scientific Literature
3.	ALA4703500	F	Antibacterial activity against hospital-acquired Methicillin -resistant Staphylococcus aureus ATCC BAA-811 by CLSI method	Staphylococcus aureus	12	ALA4699558	organism-based format	Scientific Literature
4.	ALA4703501	F	Antibacterial activity against community-acquired Methicillin -resistant Staphylococcus aureus ATCC BAA-1556 by CLSI method	Staphylococcus aureus	12	ALA4699558	organism-based format	Scientific Literature
5.	ALA4703502	B	Inhibition of Escherichia coli DNA gyrase by measuring supercoiling activity incubated for 60 mins by fluorescence based assay	Escherichia coli	36	ALA4699558	protein complex format	Scientific Literature
6.	ALA4703503	B	Inhibition of Escherichia coli topoisomerase IV by measuring relaxation activity incubated for 30 mins by fluorescence based assay	Escherichia coli	36	ALA4699558	assay format	Scientific Literature
7.	ALA4703506	F	Antibacterial activity against Escherichia coli ATCC 25922 by CLSI method	Escherichia coli	37	ALA4699558	organism-based format	Scientific Literature
8.	ALA4703507	F	Antibacterial activity against Escherichia coli ATCC 25922 in presence of PAbetaN by CLSI method	Escherichia coli	36	ALA4699558	organism-based format	Scientific Literature
9.	ALA4703508	F	Antibacterial activity against Staphylococcus aureus ATCC 29213 by CLSI method	Staphylococcus aureus	37	ALA4699558	organism-based format	Scientific Literature
10.	ALA4703509	F	Antibacterial activity against Enterococcus faecium ATCC 35667 by CLSI method	Enterococcus faecium	12	ALA4699558	organism-based format	Scientific Literature
11.	ALA4703510	F	Antibacterial activity against vancomycin-resistant Enterococcus faecium ATCC 51559 by CLSI method	Enterococcus faecium	12	ALA4699558	organism-based format	Scientific Literature
12.	ALA4703511	F	Antibacterial activity against Enterococcus faecalis ATCC 29212 by CLSI method	Enterococcus faecalis	12	ALA4699558	organism-based format	Scientific Literature
13.	ALA4703512	F	Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51575 by CLSI method	Enterococcus faecalis	12	ALA4699558	organism-based format	Scientific Literature
14.	ALA4703513	F	Antibacterial activity against Streptococcus pneumoniae ATCC 49619 by CLSI method	Streptococcus pneumoniae	12	ALA4699558	organism-based format	Scientific Literature
15.	ALA4703514	F	Antibacterial activity against Streptococcus anginosus ATCC 33397 by CLSI method	Streptococcus anginosus	12	ALA4699558	assay format	Scientific Literature
16.	ALA4703515	F	Antibacterial activity against Haemophilus influenzae ATCC 43095 by CLSI method	Haemophilus influenzae	12	ALA4699558	organism-based format	Scientific Literature
17.	ALA4703516	A	Inhibition of human topoisomerase 2alpha	Homo sapiens	5	ALA4699558	single protein format	Scientific Literature
18.	ALA4703517	B	Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay	Homo sapiens	5	ALA4699558	cell-based format	Scientific Literature
19.	ALA4703518	A	Cytotoxicity against human HepG2 cells assessed as reduction in cell viability at 10 uM incubated for 48 hrs by CCK-8 assay	Homo sapiens	5	ALA4699558	cell-based format	Scientific Literature
20.	ALA4703519	A	Cytotoxicity against human HepG2 cells assessed as reduction in cell viability at 50 uM incubated for 48 hrs by CCK-8 assay	Homo sapiens	5	ALA4699558	cell-based format	Scientific Literature